Special Issue on Immune Response in Cancer, What Immunotherapies Can Do for Us?

Submission Deadline: May 30, 2020

This special issue currently is open for paper submission and guest editor application.

Please download to know all details of the Special Issue

Special Issue Flyer (PDF)

  • Special Issue Editor
    • Marconi R Barros
      Faculty of Pharmacy, Centro Universitário Brasileiro, Recife, Brazil
    Guest Editors play a significant role in a special issue. They maintain the quality of published research and enhance the special issue’s impact. If you would like to be a Guest Editor or recommend a colleague as a Guest Editor of this special issue, please Click here to fulfill the Guest Editor application.
    • Aldo Venuti
      Tumor Immunology and Immunotherapy, Istituto Regina Elena, Istituti Fisioterapici Ospitalieri, Roma, Italy
    • Leisha A Emens
      Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, USA
    • Sjoerd H Van der Burg
      Department of Clinical Oncology, Leiden University Medical Centre, Leiden, Netherlands
    • Zihai Li
      Hollings Cancer Center, Medical University of South Carolina, Charleston, USA
    • Alexis M Kalergis
      Departamento de Genética Molecular y Microbiologia, Pontifical Catholic University of Chile, Santiago, Chile
    • Mingjun Wang
      Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, USA
  • Introduction

    Cancer is mysterious pathology. Although so many studies and considerable advances in cancer pathogenesis comprehension, diagnosis and treatment, it is still difficult to understand how it occurs and how can be prevented and eliminated. The various spots it can emerge and the complex interaction with other cells in cancer medium contribute to that. However, from a decade to now, new immunotherapeutic procedures have gained more attention, mainly because their promising results. New immune cells have been discovered and other, which has not had much importance, has now their values being recognized gradually. Therefore, this special issue aims to introduce and discuss new immunotherapies methodologies which are demonstrating great potential for solid cancers treatment. Basic and clinical studies will be demonstrated, and new possibilities for drug development can be suggested and tested.
    Biomarkers for cancer occurrence and for clinical establishment and prognosis are also on focus, showing the importance for the application of therapeutic approaches during the initial stages of cancer progression. Also, preventive measures will be encouraged, such as the development of new vaccines approaches or the improvement of existing ones. Cancer pathogenesis, paying special attention to the immunologic aspects, will be discussed and new pathways will be revealed. New interactions between cytokines and receptors as well as new roles may be suggested, and the same may occurs for immune and non-immune cells. Gradually, the interactions between these two types of cells have being revealed and demonstrated new immunotherapeutic possibilities due to the gain on understanding of cancer pathogenesis. Knowledge about recent immune cell subtypes functions may be deepened, as well as their interaction with other immune cells. At last, the evaluation of TLR multiple roles, chemokines targets, non-immune obscured functions and the double roles of immune cells may be also object of studies and reviews, and new hypothesis may be drawn.
    Aims and Scope:
    1. Cancer Immunology
    2. Cancer Immunotherapy
    3. Immune Response
    4. Drug Development
    5. Biomarkers
    6. Clinical Studies

  • Guidelines for Submission

    Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.

    Papers should be formatted according to the guidelines for authors (see: http://www.ijcocr.org/submission). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.

  • Published Papers

    The special issue currently is open for paper submission. Potential authors are humbly requested to submit an electronic copy of their complete manuscript by clicking here.

Browse journals by subject